FDA evaluating cancer link in Parkinson's drug | Reuters
Links shared publicly online about this topic.
- 1,273total visits
FDA evaluating cancer link in Parkinson's drug | Reuters
View full resource at reuters.com
Tags: Cancer, Prostate Cancer, Prostate, Disease and Condition, Drug, Men's Health, FDA, Novartis
Most Recently Shared on April 1, 2010 at 2:01 am By:
FDA evaluating prostate cancer link to Parkinson's drug Stalevo (carbidopa, levodopa, entacapone) http://bit.ly/b6CN8A - #health
FDA evaluating cancer link in Parkinson's drug | PD Online Research
pdonlineresearch.org — “FDA evaluating cancer link in Parkinson's drug | PD Online Research” View full resource at pdonlineresearch.org
Most Recently Shared on April 2, 2010 at 4:28 pm By:
PD Online Research Health Organization
FDA evaluating report of increased prostate cancer in the STRIDE-PD trial http://bit.ly/aO1V11
FDA evaluating cancer link in Parkinson's drug | Reuters
reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at reuters.com
Most Recently Shared on April 1, 2010 at 8:54 pm By:
FDA evaluating cancer link in Parkinson's drug. http://bit.ly/90Fnls
FDA evaluating cancer link in Parkinson's drug | Reuters
feeds.reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at feeds.reuters.com
Most Recently Shared on March 31, 2010 at 9:21 pm By:
FDA evaluating cancer link in Parkinson's drug http://link.reuters.com/bat95j
FDA evaluating cancer link in Parkinson's drug | Reuters
feeds.reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at feeds.reuters.com
Most Recently Shared on March 31, 2010 at 9:00 pm By:
HealthIT Policy Health News and Health IT
FDA evaluating cancer link in Parkinson's drug: NEW YORK (Reuters) - The U.S. Food and Drug Administration is eval... http://bit.ly/aaHNP9
Advertisement
